93 related articles for article (PubMed ID: 27910070)
1. Mig-6 Mouse Model of Endometrial Cancer.
Kim TH; Yoo JY; Jeong JW
Adv Exp Med Biol; 2017; 943():243-259. PubMed ID: 27910070
[TBL] [Abstract][Full Text] [Related]
2. MIG-6 suppresses endometrial epithelial cell proliferation by inhibiting phospho-AKT.
Yoo JY; Kang HB; Broaddus RR; Risinger JI; Choi KC; Kim TH
BMC Cancer; 2018 May; 18(1):605. PubMed ID: 29843645
[TBL] [Abstract][Full Text] [Related]
3. MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial cells.
Yoo JY; Yang WS; Lee JH; Kim BG; Broaddus RR; Lim JM; Kim TH; Jeong JW
Oncogene; 2018 Jan; 37(2):255-262. PubMed ID: 28925396
[TBL] [Abstract][Full Text] [Related]
4. Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer.
Kim TH; Lee DK; Cho SN; Orvis GD; Behringer RR; Lydon JP; Ku BJ; McCampbell AS; Broaddus RR; Jeong JW
Cancer Res; 2013 Aug; 73(16):5090-9. PubMed ID: 23811943
[TBL] [Abstract][Full Text] [Related]
5. A calcium-dependent phospholipase A2 (cPLA2) expression is regulated by MIG-6 during endometrial tumorigenesis.
Teasley HE; Jeong MP; Kim TH
Biochem Biophys Res Commun; 2019 Mar; 511(1):129-134. PubMed ID: 30773264
[TBL] [Abstract][Full Text] [Related]
6. Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease.
Jeong JW; Lee HS; Lee KY; White LD; Broaddus RR; Zhang YW; Vande Woude GF; Giudice LC; Young SL; Lessey BA; Tsai SY; Lydon JP; DeMayo FJ
Proc Natl Acad Sci U S A; 2009 May; 106(21):8677-82. PubMed ID: 19439667
[TBL] [Abstract][Full Text] [Related]
7. The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression.
Kim TH; Franco HL; Jung SY; Qin J; Broaddus RR; Lydon JP; Jeong JW
Oncogene; 2010 Jul; 29(26):3770-80. PubMed ID: 20418913
[TBL] [Abstract][Full Text] [Related]
8. Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
Kim TH; Yoo JY; Kim HI; Gilbert J; Ku BJ; Li J; Mills GB; Broaddus RR; Lydon JP; Lim JM; Yoon HG; Jeong JW
Cancer Res; 2014 Dec; 74(24):7371-82. PubMed ID: 25377472
[TBL] [Abstract][Full Text] [Related]
9. MIG-6 Is Critical for Progesterone Responsiveness in Human Complex Atypical Hyperplasia and Early-Stage Endometrial Cancer.
Jeong O; Broaddus RR; Lessey BA; Risinger JI; Hunter MI; Kim TH
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498921
[TBL] [Abstract][Full Text] [Related]
10. Mig-6 regulates endometrial genes involved in cell cycle and progesterone signaling.
Yoo JY; Kim TH; Lee JH; Dunwoodie SL; Ku BJ; Jeong JW
Biochem Biophys Res Commun; 2015 Jul; 462(4):409-14. PubMed ID: 25976672
[TBL] [Abstract][Full Text] [Related]
11. Alterations in Wnt-β-catenin and Pten signalling play distinct roles in endometrial cancer initiation and progression.
van der Zee M; Jia Y; Wang Y; Heijmans-Antonissen C; Ewing PC; Franken P; DeMayo FJ; Lydon JP; Burger CW; Fodde R; Blok LJ
J Pathol; 2013 May; 230(1):48-58. PubMed ID: 23288720
[TBL] [Abstract][Full Text] [Related]
12. Mutual contribution of Pten and estrogen to endometrial carcinogenesis in a PtenloxP/loxP mouse model.
Saito F; Tashiro H; To Y; Ohtake H; Ohba T; Suzuki A; Katabuchi H
Int J Gynecol Cancer; 2011 Nov; 21(8):1343-9. PubMed ID: 21989218
[TBL] [Abstract][Full Text] [Related]
13. PI3K/PTEN/AKT Genetic Mouse Models of Endometrial Carcinoma.
Joshi A; Ellenson LH
Adv Exp Med Biol; 2017; 943():261-273. PubMed ID: 27910071
[TBL] [Abstract][Full Text] [Related]
14. Pathology of Endometrial Carcinoma.
Lax SF
Adv Exp Med Biol; 2017; 943():75-96. PubMed ID: 27910065
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of mitogen-inducible gene 6 triggers antitumor effect and attenuates progesterone resistance in endometrial carcinoma cells.
Xu W; Zhu S; Zhou Y; Jin Y; Dai H; Wang X
Cancer Gene Ther; 2015 Nov; 22(11):536-41. PubMed ID: 26450625
[TBL] [Abstract][Full Text] [Related]
16. Steroid hormone intervenes in the endometrial tumorigenesis of pten ablation.
Kim HI; Kim TH; Lim JM; Jeong JW
J Cancer Prev; 2013 Dec; 18(4):313-21. PubMed ID: 25337560
[TBL] [Abstract][Full Text] [Related]
17. The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten.
Liang X; Daikoku T; Terakawa J; Ogawa Y; Joshi AR; Ellenson LH; Sun X; Dey SK
PLoS Genet; 2018 Aug; 14(8):e1007630. PubMed ID: 30142194
[TBL] [Abstract][Full Text] [Related]
18. Distinct temporal and spatial activities of RU486 on progesterone receptor function in reproductive organs of ovariectomized mice.
Han SJ; Tsai SY; Tsai MJ; O'Malley BW
Endocrinology; 2007 May; 148(5):2471-86. PubMed ID: 17303655
[TBL] [Abstract][Full Text] [Related]
19. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
[TBL] [Abstract][Full Text] [Related]
20. Gene expression analysis reveals a signature of estrogen receptor activation upon loss of Pten in a mouse model of endometrial cancer.
Lian Z; De Luca P; Di Cristofano A
J Cell Physiol; 2006 Aug; 208(2):255-66. PubMed ID: 16688764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
